| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33840201_HAS_TOPIC_C0003062> <https://research.tib.eu/covid-19/entity/33840201_HAS_TOPIC_C0005823> <https://research.tib.eu/covid-19/entity/33840201_HAS_TOPIC_C0020538> <https://research.tib.eu/covid-19/entity/33840201_HAS_TOPIC_C0035096> <https://research.tib.eu/covid-19/entity/33840201_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33840201_HAS_TOPIC_C0086907> <https://research.tib.eu/covid-19/entity/33840201_HAS_TOPIC_C0428883> <https://research.tib.eu/covid-19/entity/33840201_HAS_TOPIC_C0871470> <https://research.tib.eu/covid-19/entity/33840201_HAS_TOPIC_C0949236> <https://research.tib.eu/covid-19/entity/33840201_HAS_TOPIC_C2713498> <https://research.tib.eu/covid-19/entity/33840201_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33840201_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'From the Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, TX.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Fatima_Naureen> <https://research.tib.eu/covid-19/entity/Hussain_Tahir> <https://research.tib.eu/covid-19/entity/Patel_Sanket_N>
?:doi	10.1161/HYPERTENSIONAHA.120.11941
?:doi	<https://research.tib.eu/covid-19/entity/10.1161/HYPERTENSIONAHA.120.11941>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_N.I.H.%2C_Extramural> <https://research.tib.eu/covid-19/entity/Review>
?:journal	Hypertension (Dallas, Tex. : 1979)
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33840201>
?:pmid	<https://research.tib.eu/covid-19/entity/33840201>
?:pmid	33840201
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0040300_PART_OF_C0001675> <https://research.tib.eu/covid-19/entity/C0242291_LOCATION_OF_C0540511>
?:title	Angiotensin II Type 2 Receptor: A Target for Protection Against Hypertension, Metabolic Dysfunction, and Organ Remodeling.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33840201>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33840201>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all